MeiraGTx Holdings PLC (MGTX)
US$ 6.415.08%
Price Chart
Key Statistics
Market Cap
$ 680.69M
P/E Ratio
0.00
Revenue (TTM)
$ 34.51M
Volume
272.03K
52W High
$ 8.75
52W Low
$ 3.85
Dividend Yield
0.00%
Beta
1.18
Technicals
50-Day MA
6.2059
200-Day MA
6.155
52 Week High
8.75
52 Week Low
3.85
About MGTX
MeiraGTx Holdings plc, a clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, in.
Employees
372
Headquarters
New York, NY
CEO
Dr. Alexandria Forbes Ph.D.
Latest News
MeiraGTx Holdings (MGTX) Soars 3.72% on CEO Share Sale, Rating Upgrade - AInvest
3 days ago • Google News
MeiraGTx Holdings: Gaining Regulatory Focus (NASDAQ:MGTX) - Seeking Alpha
2025-03-25 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg